نتایج جستجو برای: eluting stents outcome assessment

تعداد نتایج: 903119  

Journal: :Lancet 2014
Thomas Pilgrim Dik Heg Marco Roffi David Tüller Olivier Muller André Vuilliomenet Stéphane Cook Daniel Weilenmann Christoph Kaiser Peiman Jamshidi Therese Fahrni Aris Moschovitis Stéphane Noble Franz R Eberli Peter Wenaweser Peter Jüni Stephan Windecker

BACKGROUND Refinements in stent design affecting strut thickness, surface polymer, and drug release have improved clinical outcomes of drug-eluting stents. We aimed to compare the safety and efficacy of a novel, ultrathin strut cobalt-chromium stent releasing sirolimus from a biodegradable polymer with a thin strut durable polymer everolimus-eluting stent. METHODS We did a randomised, single-...

Journal: :JAMA 2012
Lorenz Räber Henning Kelbæk Miodrag Ostojic Andreas Baumbach Dik Heg David Tüller Clemens von Birgelen Marco Roffi Aris Moschovitis Ahmed A Khattab Peter Wenaweser Robert Bonvini Giovanni Pedrazzini Ran Kornowski Klaus Weber Sven Trelle Thomas F Lüscher Masanori Taniwaki Christian M Matter Bernhard Meier Peter Jüni Stephan Windecker

CONTEXT The efficacy and safety of drug-eluting stents compared with bare-metal stents remains controversial in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). OBJECTIVE To compare stents eluting biolimus from a biodegradable polymer with bare-metal stents in primary PCI. DESIGN, SETTING, AND PATIENTS A prospectiv...

Journal: :Revista espanola de cardiologia 2014
Petri O Tuomainen Jussi Sia Wail Nammas Matti Niemelä Juhani K E Airaksinen Fausto Biancari Pasi P Karjalainen

INTRODUCTION AND OBJECTIVES We performed a pooled analysis based on patient-level data from the TITAX-AMI and BASE-ACS trials to evaluate the outcome of titanium-nitride-oxide-coated bioactive stents vs drug-eluting stents in patients with ST-segment elevation myocardial infarction at 2-year follow-up. METHODS The TITAX-AMI trial compared bioactive stents with paclitaxel-eluting stents in 425...

Journal: :Singapore medical journal 2004
K W Lau A Johan U Sigwart J S Hung

The undisputed superiority of stents over conventional balloon angioplasty has resulted in a plethora of stents in clinical use. Recent data, however, have indicated not all stent models are the same. Nuances in stent design and construction have impacted significantly on the immediate and long-term clinical outcome. Among the stainless steel stents, those with multicellular or tubular designs ...

2012
G Dimitrova D B Tulman S D Bergese

Significant advancements in percutaneous treatment of coronary artery disease have been achieved with the introduction of bare metal stents. They have two major drawbacks: acute/subacute stent thrombosis, successfully managed with antiplatelet therapy immediately after stent implantation; and in-stent restenosis, prevention of which has been achieved with the development of drug-eluting stents....

2013
Sripal Bangalore Bora Toklu Mario Fusaro Edward L Hannan

Objective To compare the efficacy and safety of biodegradable polymer drug eluting stents with those of bare metal stents and durable polymer drug eluting stents. Design Mixed treatment comparison meta-analysis of 258 544 patient years of follow-up from randomized trials. Data sources and study selection PubMed, Embase, and Central were searched for randomized trials comparing any of the Food a...

2017
Benjamin D. Hunt Matthew A. Popplewell Huw Davies Lewis Meecham Hugh Jarrett Gareth Bate Margaret Grant Smitaa Patel Catherine Hewitt Lazaros Andronis Jonathan J. Deeks Andrew Bradbury

BACKGROUND Severe limb ischaemia (SLI) is defined as the presence of rest pain and/or tissue loss secondary to lower extremity atherosclerotic peripheral arterial disease. The superficial femoral and popliteal arteries are the most commonly diseased vessels in such patients and are being increasingly treated using endovascular revascularisation techniques. However, it is currently unknown wheth...

Journal: :Revista espanola de cardiologia 2013
Salvatore Cassese Steffen Desch Adnan Kastrati Robert A Byrne Lamin King Tomohisa Tada Bernward Lauer Albert Schömig Holger Thiele Jürgen Pache

INTRODUCTION AND OBJECTIVES The angiographic and clinical efficacy of polymer-free sirolimus-eluting stents vs polymer-based paclitaxel-eluting stents remain a matter of debate. We sought to investigate angiographic and clinical measures of efficacy of polymer-free sirolimus-eluting stents vs polymer-based paclitaxel-eluting stents. METHODS Patient data from the randomized intracoronary stent...

Journal: :Revista espanola de cardiologia 2015
Rodrigo Estévez-Loureiro Armando Pérez de Prado Claudia Pérez-Martínez Carlos Cuellas-Ramón Marta Regueiro-Purriños José M Gonzalo-Orden María López-Benito María Molina-Crisol Luis Duocastella-Codina Felipe Fernández-Vázquez

INTRODUCTION AND OBJECTIVES Initial preclinical studies are required during the process of improving polymers, platforms, and drug-eluting systems for new coronary stent designs. Our objective was to analyze the efficacy and safety of new drug-eluting stent models compared with a conventional stent and commercialized drug-eluting stents in an experimental model with healthy porcine coronary art...

Journal: :Journal of interventional cardiology 2003
Sigmund Silber

In Germany, four different drug eluting stents (DES) systems are currently commercially available. Whereas sirolimus has been clinically tested in only a single type of stent with a single type of coating in only a single dose, paclitaxel has been tested on various stent designs, in various dose densities, and in various release formulations with or without a polymer carrier. Therefore, the que...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید